Skip to main content
Premium Trial:

Request an Annual Quote

Scandinavian DNA-Analysis Companies Merge

NEW YORK (GenomeWeb News) - Norwegian company Genpoint has merged with Swedish firm MBS, the companies said today in a joint release.
 
The companies market DNA-analysis instruments and reagents for clinical diagnostics that have been used for tuberculosis, staph infections, and sexually transmitted diseases.
 
Erik Hornes, Genpoint's CEO, said the combined companies will continue to work on bacterial infections and will also shift to viral infections and cancer.
 
The companies said the merger will help establish new positions beyond their footholds in Norway and Sweden and their client base in Finland and Denmark.
 
The companies are expecting combined 2006 revenue of NOK 8 million ($1.3 million) and 2007 revenue between NOK 15 and NOK 20 million.
 
Financial terms of the deal were not released.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.